Back to News
Market Impact: 0.05
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
Source: GlobeNewswire
Healthcare & Biotech
The company said an upcoming presentation will provide additional detail on its mission to advance potentially transformative therapies for autoimmune and inflammatory diseases. The statement includes no clinical data, financial results, regulatory updates, or commercialization milestones.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Premarket movers: Intel jumps on SK Hynix memory-chip talks, J.B. Hunt slides
- Japan has a problematic age gap: 100,000-plus residents are over 100 and the pension system is buckling
- Arrowhead Pharmaceuticals at H.C. Wainwright: launch and pipeline widen
- The MLB and its Dominican pipeline is selling false promises and shady contracts to children as young as 11
- A healthcare provider is set up for a big move higher, according to the charts
- The Download: AI’s trillion-dollar gamble and OpenAI’s biology data bid